AFFIRM-AHF (Includerend)
A randomised, double-blind placebo controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron deficient patients admitted for acute heart failure (AFFIRM-AHF)
- Middel
- ferric carboxymaltose
- Populatie
- hartfalen
- Fase
- IV
- Jaar aanvang
- 2016
- Meer informatie
- ClinicalTrials.gov